Altered BRCA2 carriers have a 5–10% lifetime breast cancer risk, 15–61% risk of PC, 3–5% risk of pancreatic cancer, and 3–5% risk of melanoma (Rauscher et al. 2018). This evidence concerns the gene BRCA2 and pancreatic neoplasm.